谈判 发表于 2025-3-23 11:37:53

Submitted on: 14 September 2003.
Revised on: 25 September 2003.
Accepted on: 12 October 2003.
NEUROMOLECULAR MEDICINE---HUMANA PRESS INC

delta-waves 发表于 2025-3-23 14:47:07

Submitted on: 26 December 2003.
Revised on: 10 January 2004.
Accepted on: 03 February 2004.
NEUROMOLECULAR MEDICINE

Panther 发表于 2025-3-23 19:59:40

http://reply.papertrans.cn/3/230/22959/22959-13.png

Debate 发表于 2025-3-24 01:27:25

http://reply.papertrans.cn/3/230/22959/22959-14.png

烦躁的女人 发表于 2025-3-24 02:38:37

http://reply.papertrans.cn/3/230/22959/22959-15.png

exclusice 发表于 2025-3-24 07:49:17

Submitted on: 18 June 2015.
Revised on: 09 July 2015.
Accepted on: 23 July 2015.
NEUROMOLECULAR MEDICINE---HUMANA PRESS INC

Control-Group 发表于 2025-3-24 12:22:03

Submitted on: 09 February 2001.
Revised on: 26 February 2001.
Accepted on: 12 March 2001.
NEUROMOLECULAR MEDICINE

缺陷 发表于 2025-3-24 16:40:53

http://reply.papertrans.cn/3/230/22959/22959-18.png

mortgage 发表于 2025-3-24 21:39:25

Submitted on: 10 November 2014.
Revised on: 26 November 2014.
Accepted on: 01 December 2014.
NEUROMOLECULAR MEDICINE---HUMANA PRESS INC

Spina-Bifida 发表于 2025-3-24 23:32:49

http://reply.papertrans.cn/3/230/22959/22959-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊NEUROMOLECULAR MEDICINE 2024/2025影响因子:3.382 (NEUROMOL MED) (1535-1084). (NEUROSCIENCES)(神经科学)Science Citation Ind